- Home
- BHC
as 03-28-2025 4:00pm EST
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
| Founded: | N/A | Country: | Canada |
| Employees: | N/A | City: | QUEBEC |
| Market Cap: | 2.6B | IPO Year: | N/A |
| Target Price: | $7.20 | AVG Volume (30 days): | 1.4M |
| Analyst Decision: | Hold | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.13 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.96 - $11.46 | Next Earning Date: | 04-30-2025 |
| Revenue: | $9,625,000,000 | Revenue Growth: | 9.91% |
| Revenue Growth (this year): | 4.76% | Revenue Growth (next year): | 2.05% |
Latest Bausch Health Companies Inc. News
BHC Breaking Stock News: Dive into BHC Ticker-Specific Updates for Smart Investing
StockStory
2 days ago
Why Bausch + Lomb (BLCO) Stock Is Nosediving
Medical Device Network
2 days ago
Bausch + Lomb announces intraocular lens recall
MT Newswires
2 days ago
Sector Update: Health Care Stocks Flat to Higher Premarket Thursday
MT Newswires
2 days ago
Bausch + Lomb Recalls Intraocular Lense Products After Reports of Inflammatory Reactions
ACCESS Newswire
2 days ago
Bausch Health to Announce First Quarter Results on April 30
MT Newswires
4 days ago
Bausch Health Prices Upsized Private Offering of Senior Secured Notes
ACCESS Newswire
4 days ago
Bausch Health Announces Pricing of Upsized Private Offering of Senior Secured Notes
Simply Wall St.
5 days ago
Discover 3 Top Growth Companies With Significant Insider Ownership
Compare BHC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BHC Bausch Health Companies Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.